You Searched For "covid 19 vaccine maker adar poonawalla" and got 20 results
Sort By:
2 mins read
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…
Kelly Cloonan
2 mins read
Global rollout of 12 billion Covid-19 vaccine doses largest-ever, but access is an issue: WHO
Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network …
1 min read
Covovax vaccine to get approval as a booster in 10-15 days: Adar Poonawalla
Asked about states and districts not getting Covishield vaccine, he said there is ample stock wi…
PTI
2 mins read
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
3 mins read
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
2 mins read
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion
In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…
PTI
4 mins read
SII’s Adar Poonawalla estimates two more months of COVID-19 vaccine shortage in India — and the blame game is heating up
Not only has the number of COVID-19 cases surging in the world’s second most populous country but t…
1 min read
Serum Institute to roll out COVID-19 vaccine for children in six months, says CEO Adar Poonawalla
"We haven't seen a lot of severe disease in children. Fortunately, the panic is not there fo…
PTI
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
3 mins read
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
2 mins read
The leader of one of the world's biggest vaccine manufacturers said he fled India because of menacing threats
Adar Poonawalla told The Times of London he faced an "unprecedented" environment of "expectation an…
Yelena Dzhanova
2 mins read
More than 3.3 million people lost life to COVID-19 in 2021 — more than HIV, malaria and tuberculosis related deaths combined in 2020
The World Health Organisation (WHO), on Tuesday, revealed that more than 3.3 million people lost th…
1 min read
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
3 mins read
India has its eyes and hopes pinned on Adar Poonawalla— the world’s biggest vaccine maker who will be speaking at the Global Trends Festival 2020
If developing a vaccine for COVID-19 virus is the most important thing, the 39-year old Adar Poonaw…
2 mins read
The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla
The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…
3 mins read
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
1 min read
Covishield maker Adar Poonawalla gets dose of his own vaccine
Pune, Jan 16 (IANS) In a huge confidence booster, Serum Institute of India's (SII) Chief Executive …
3 mins read
Coronavirus vaccine Covishield completes enrolment of phase-3 clinical trials under ICMR, Serum Institute's partnership
"The partnership is a stellar example of private-public institutes collaborating to mitigate the…
PTI
2 mins read
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…